Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

WEST PHARMACEUTICAL SERVICES INC Director's Dealing 2005

Sep 1, 2005

30339_dirs_2005-09-01_765d5689-b235-4bdf-b2d4-2b0a04eb486a.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: WEST PHARMACEUTICAL SERVICES INC ((WST))
CIK: 0000105770
Period of Report: 2005-08-31

Reporting Person: ELLERS STEVEN A (COO & President)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2005-08-31 Common Stock M 6080 $14.7032 Acquired 91110.4663 Direct
2005-08-31 Common Stock S 6080 $28.0950 Disposed 85030.4663 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2005-08-31 Stock Option (Right to Buy) $14.7032 M 6080 Disposed 2007-08-05 Common Stock (6080.00) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 2781.6880 Indirect
Common Stock 16379.9403 Indirect

Footnotes

F1: Reflects additional shares purchased through dividend reinvestments based on most recent plan statement.